Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8650
pubmed:dateCreated
1989-7-6
pubmed:abstractText
The clinical and immunological evolution of lesions in cutaneous leishmaniasis was assessed after treatment with human recombinant gamma interferon (rIFN-gamma). 3 weeks after rIFN-gamma treatment of lesions due to Leishmania braziliensis guyanensis, 12/13 had become smaller compared with 6/13 control lesions; only 4 treated lesions were free of parasites. 9 of 13 L tropica lesions treated with rIFN-gamma resolved completely within 4-8 weeks of treatment. An acute inflammatory reaction around treated lesions was more common in lesions due to L tropica. There were no other local or systemic adverse reactions. Histological and immunohistochemical studies indicate that local application of rIFN-gamma enhances cell-mediated immune responses and thus promotes healing of cutaneous leishmaniasis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0140-6736
pubmed:author
pubmed:issnType
Print
pubmed:day
10
pubmed:volume
1
pubmed:owner
NLM
pubmed:authorsComplete
N
pubmed:pagination
1287-92
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:2566825-Acute Disease, pubmed-meshheading:2566825-Administration, Topical, pubmed-meshheading:2566825-Adolescent, pubmed-meshheading:2566825-Adult, pubmed-meshheading:2566825-Animals, pubmed-meshheading:2566825-Antibodies, Protozoan, pubmed-meshheading:2566825-Biopsy, pubmed-meshheading:2566825-Brazil, pubmed-meshheading:2566825-Clinical Trials as Topic, pubmed-meshheading:2566825-Female, pubmed-meshheading:2566825-HLA-DR Antigens, pubmed-meshheading:2566825-Humans, pubmed-meshheading:2566825-Immunity, Cellular, pubmed-meshheading:2566825-Immunoglobulin E, pubmed-meshheading:2566825-Injections, Subcutaneous, pubmed-meshheading:2566825-Interferon-gamma, pubmed-meshheading:2566825-Leishmania braziliensis, pubmed-meshheading:2566825-Leishmaniasis, pubmed-meshheading:2566825-Leukocyte Count, pubmed-meshheading:2566825-Male, pubmed-meshheading:2566825-Middle Aged, pubmed-meshheading:2566825-Receptors, Interleukin-2, pubmed-meshheading:2566825-Recombinant Proteins, pubmed-meshheading:2566825-Skin, pubmed-meshheading:2566825-Syria, pubmed-meshheading:2566825-T-Lymphocytes, pubmed-meshheading:2566825-Time Factors
pubmed:year
1989
pubmed:articleTitle
Effects of intradermal gamma-interferon in cutaneous leishmaniasis.
pubmed:affiliation
Landesinstitut für Tropenmedizin, Berlin, Federal Republic of Germany.
pubmed:publicationType
Journal Article, Clinical Trial, Controlled Clinical Trial